Celgene $500 Million Notes Offering
Davis Polk advised the sole book-running manager on an SEC-registered offering by Celgene Corporation of $500 million aggregate principal amount of 2.250% senior notes due 2021. …
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Spark Therapeutics Follow-On Offering
Davis Polk advised the representative of the underwriters in connection with the $402.5 million public offering of 5,296,053 shares of common stock of Spark Therapeutics, Inc. The…
Davis Polk Advises Noble on the Sale of Noble Americas Gas & Power Corp. to Mercuria Energy America
Davis Polk is advising Noble Group Limited on the sale of its wholly-owned subsidiary Noble Americas Gas & Power Corp. to Mercuria Energy America, Inc. The transaction, which is…
Mersana Therapeutics, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $75 million initial public offering of common stock of Mersana Therapeutics…
Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 5,050,505 shares of common stock of…
Galapagos NV €363.9 Million Follow-On Offering of American Depositary Shares
Davis Polk advised the sole book-running manager in connection with Galapagos NV’s offering of 4,312,500 ordinary shares in the form of American depositary shares, which includes the full…
REGENXBIO Follow-On Common Stock Offering
Davis Polk advised the representatives of the underwriters in connection with the $75.9 million offering of 3,700,000 shares of common stock of REGENXBIO Inc. The common stock is listed on…
Abbott Laboratories $2.9 Billion Exchange Offers and Consent Solicitations
Davis Polk advised the joint lead dealer managers in connection with the registered offers by Abbott Laboratories to exchange certain outstanding debt securities of St. Jude Medical,…
Editas Medicine, Inc. $90 Million Follow-On Offering
Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the $90 million follow-on offering of 4,000,000 shares of common stock…
SUEZ acquisition of GE Water & Process Technologies from General Electric
Davis Polk is advising SUEZ on its $3.415 billion acquisition of GE Water & Process Technologies from General Electric Company with Caisse de dépôt et placement du Québec. The…